Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis
Launched by LARKIN COMMUNITY HOSPITAL · Mar 9, 2021
Trial Information
Current as of June 03, 2025
Withdrawn
Keywords
ClinConnect Summary
Allergic rhinitis is defined as the symptoms of sneezing, nasal itching, airflow obstruction and, mostly, clear nasal discharge caused by IgE-mediated reactions against inhaled allergens and involving mucosal inflammation driven by T cells (Th2) auxiliary type 2. pollens and molds, as well as allergens from perennial interiors, such as dust mites, pets, pests and some molds. The pattern of dominant allergens depends on the geographic region and degree of urbanization, but the general prevalence of sensitization to allergens does not vary among census districts in the United States.2 Sensiti...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. No oral steroids
- • 2. No oral antihistamine
- • 3. No Nafasoline If the patient needs rescue treatment, he will go to the intervention arm with chlorpheniramine or with the combination of chlorpheniramine and fluticasone. If a participant experienced a severe acute nasal block, the investigator could authorize the use of a short course of oxymetazoline spray for a maximum of 3 days and a maximum total of 1 day during the treatment period. Oxymetazoline should not be used within 24 hours of a scheduled visit during the study.
- Exclusion Criteria:
- • 1. Large (grade 3) polyps, indicating severe nasal obstruction
- • 2. Surgical treatment for nasal polyps during the last 3 months
- • 3. Cystic fibrosis
- • 4. Purulent nasal infection
- • 5. Allergic rhinitis
- • 6. Any disease likely to interfere with the study parameters or which gave evidence of any serious or unstable concurrent disease or psychological disorder
About Larkin Community Hospital
Larkin Community Hospital is a leading healthcare institution dedicated to providing comprehensive medical services and advancing clinical research. With a commitment to enhancing patient care through innovative therapies and evidence-based practices, the hospital actively engages in clinical trials that explore new treatment options across various medical disciplines. Larkin Community Hospital's experienced research team collaborates with healthcare professionals and regulatory bodies to ensure the highest standards of safety and efficacy in all clinical studies, ultimately aiming to improve health outcomes and contribute to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
South Miami, Florida, United States
Patients applied
Trial Officials
Marcos A Sanchez-Gonzalez
Principal Investigator
Larkin Health System
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials